MA28533B1 - Schema de traitement pour des derives de camptothecine - Google Patents

Schema de traitement pour des derives de camptothecine

Info

Publication number
MA28533B1
MA28533B1 MA29387A MA29387A MA28533B1 MA 28533 B1 MA28533 B1 MA 28533B1 MA 29387 A MA29387 A MA 29387A MA 29387 A MA29387 A MA 29387A MA 28533 B1 MA28533 B1 MA 28533B1
Authority
MA
Morocco
Prior art keywords
treatment scheme
camptothecine
derivatives
camptothecine derivatives
scheme
Prior art date
Application number
MA29387A
Other languages
English (en)
Inventor
Margaret Ma Woo
Horst F Schran
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA28533B1 publication Critical patent/MA28533B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA29387A 2004-03-26 2006-10-13 Schema de traitement pour des derives de camptothecine MA28533B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55672904P 2004-03-26 2004-03-26

Publications (1)

Publication Number Publication Date
MA28533B1 true MA28533B1 (fr) 2007-04-03

Family

ID=34963082

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29387A MA28533B1 (fr) 2004-03-26 2006-10-13 Schema de traitement pour des derives de camptothecine

Country Status (15)

Country Link
US (1) US20080262014A1 (fr)
EP (1) EP1732554A2 (fr)
JP (1) JP2007530495A (fr)
KR (1) KR20070010133A (fr)
CN (2) CN1929842A (fr)
AU (2) AU2005226932B2 (fr)
BR (1) BRPI0509240A (fr)
CA (1) CA2559532A1 (fr)
IL (1) IL178106A0 (fr)
MA (1) MA28533B1 (fr)
NO (1) NO20064907L (fr)
RU (1) RU2006137657A (fr)
TN (1) TNSN06305A1 (fr)
WO (1) WO2005092302A2 (fr)
ZA (1) ZA200607422B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050418A1 (it) * 2005-08-04 2007-02-05 Sigma Tau Ind Farmaceuti Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1044977B1 (fr) * 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Dérivés de camptothécine à activité anti-tumorale

Also Published As

Publication number Publication date
CA2559532A1 (fr) 2005-10-06
AU2009202656A1 (en) 2009-07-23
CN1929842A (zh) 2007-03-14
AU2005226932A1 (en) 2005-10-06
EP1732554A2 (fr) 2006-12-20
AU2005226932B2 (en) 2009-07-09
WO2005092302A3 (fr) 2006-08-03
KR20070010133A (ko) 2007-01-22
JP2007530495A (ja) 2007-11-01
BRPI0509240A (pt) 2007-09-04
CN101480395A (zh) 2009-07-15
IL178106A0 (en) 2006-12-31
TNSN06305A1 (en) 2007-12-03
RU2006137657A (ru) 2008-05-10
NO20064907L (no) 2006-12-20
WO2005092302A2 (fr) 2005-10-06
US20080262014A1 (en) 2008-10-23
ZA200607422B (en) 2007-12-27

Similar Documents

Publication Publication Date Title
IL208350A0 (en) Aminodihydrothiazine derivatives as bace inhibitors for the treatment of alzheimer's disease
SI2987796T1 (sl) Halogen-substituirani boronoftalidi za zdravljenje okužb
ZA200710563B (en) Compounds for the treatment of multi-drug resistant bacterial infections
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
FR2932478B1 (fr) Composes utiles pour le traitement des cancers.
MA28791B1 (fr) Derives de piperazine convenant pour le traitement de troubles gastro-intestinaux
EP2331520A4 (fr) Dérivés de rosamine comme agents pour le traitement d'un cancer
MA28871B1 (fr) Derives tricycliques accoles pour le traitement de troubles psychotiques
EP2376091A4 (fr) Nouvelles cibles pour le traitement de l'hypercholestérolémie
MA29097B1 (fr) Composes pour le traitement des infections virales par flaviviridae
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
EP2296654A4 (fr) Dérivés de 8-hydroxyquinoline pour le traitement d'hémopathies malignes
BRPI0808043A2 (pt) Compostos tricíclicos úteis no tratamento de distúrbios de ferro.
EP1804787A4 (fr) Composition flavonoide pour le traitement des maladies bucco-dentaires
EP2225196A4 (fr) Inhibiteurs de cystéine-protéases pour le traitement de maladies parasitaires
EP1817311A4 (fr) Derives pyridyle 2,3,4,6-substitues utiles comme inhibiteurs de la beta-secretase pour le traitement de la maladie d'alzheimer
BRPI0821026A2 (pt) Derivados de alfa-minoamidas úteis no tratamento de transtornos psiquiátricos
EP2015741A4 (fr) Inhibiteurs de l'histone desacétylase pour le traitement de la neurodégénération
DE602005015963D1 (de) Estergebundene makrolide, die sich für die behandlung von mikrobiellen infektionen eignen
EP1765735A4 (fr) Procede de traitement des boues
FR2873372B1 (fr) Procede de preparation de derives n-piperidino-1,5- diphenylpyrazole-3-carboxamide
EP1732549A4 (fr) Procedes pour le traitement de synucleinopathies
ATE410166T1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate zur behandlung von unfruchtbarkeit
ITRM20050179A1 (it) Composizione impiegabile per il trattamento delle patologie paradontali.
FR2885030B1 (fr) Machine pour le traitement de volatiles vivants